Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1957 1
1958 2
1959 1
1960 3
1961 2
1962 1
1979 1
2002 1
2003 15
2004 19
2005 14
2006 13
2007 21
2008 25
2009 23
2010 37
2011 24
2012 25
2013 18
2014 21
2015 11
2016 26
2017 18
2018 10
2019 11
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

314 results
Results by year
Filters applied: . Clear all
Page 1
The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice: A clinical trial.
Song JC, et al. PLoS One 2018 - Clinical Trial. PMID 30427948 Free PMC article.
METHODS: 18 patients with obstructive jaundice and 12 non-jaundiced patient controls received dexmedetomidine, 1 μg/kg, over 10 min. ...CONCLUSIONS: This study demonstrates that the clearance and distribution volume of dexmedetomidine were decreased in patients with obstructive jaundice. ...
METHODS: 18 patients with obstructive jaundice and 12 non-jaundiced patient controls received dexmedetomidine, 1 μg/kg, over 1 …
Elevated endogenous opioids in obstructive jaundice: The possible skin mechanisms.
Li X, et al. Med Hypotheses 2018. PMID 29857894
In the course of obstructive jaundice, all these cells had the potential to be activated by different molecular mechanisms. And some cells like keratinocyte and inflammation cells had been proved to correlate with elevated plasma levels of enkephalin and beta-endorphin in patients with obstructive jaundice. ...These skin-cell related mechanisms should be further studied to resolve the puzzle of elevated peripheral opiate tone during obstructive jaundice....
In the course of obstructive jaundice, all these cells had the potential to be activated by different molecular mechanisms. An …
Murine model of long-term obstructive jaundice.
Aoki H, et al. J Surg Res 2016. PMID 27916350 Free PMC article.
The pCL model demonstrated acute inflammation due to obstructive jaundice 3 d after ligation but jaundice rapidly decreased by day 7. ...The LHML model was identified to be the most feasible model to study the effect of long-term obstructive jaundice....
The pCL model demonstrated acute inflammation due to obstructive jaundice 3 d after ligation but jaundice rapidly decre …
Cholemic nephropathy - Historical notes and novel perspectives
Krones E, et al. Biochim Biophys Acta Mol Basis Dis 2018 - Review. PMID 28851656 Free article.
Cholemic nephropathy, also known as bile cast nephropathy, supposedly represents a widely underestimated but important cause of renal dysfunction in cholestasic or advanced liver diseases with jaundice. ...
Cholemic nephropathy, also known as bile cast nephropathy, supposedly represents a widely underestimated but important cause of renal dysfun …
The effects of obstructive jaundice on the brain: An experimental study.
Dilektasli E, et al. Asian J Surg 2016. PMID 26187138 Free article.
BACKGROUND/OBJECTIVE: The study aims to evaluate the alterations in the brain due to oxidative stress and lipid peroxidation resulting from obstructive jaundice. ...
BACKGROUND/OBJECTIVE: The study aims to evaluate the alterations in the brain due to oxidative stress and lipid peroxidation resulting from …
The application of Compont gel in chronic obstructive jaundice rats model.
Luo WW, et al. Acta Cir Bras 2019. PMID 31166460 Free PMC article.
HE staining, Masson staining and immunohistochemistry were used to detect liver pathology. RESULTS: Group B showed a fluctuant development of jaundice, obstructive degree reached a peak at 2 weeks, and decreased from 3 weeks. ...CONCLUSION: Intra-biliary injection of Compont gel is different from the classic obstructive jaundice animal model caused by classic bile duct ligation, which can provide an ideal rat model of chronic obstructive jaundice with liver fibrosis....
HE staining, Masson staining and immunohistochemistry were used to detect liver pathology. RESULTS: Group B showed a fluctuant develo …
Preoperative biliary stenting versus operation first in jaundiced patients due to malignant lesions in the pancreatic head: A meta-analysis of current literature
Scheufele F, et al. Surgery 2017 - Review. PMID 28043693
There is no clear consensus on whether to treat malignant obstructive jaundice with preoperative biliary drainage prior to operative intervention or to proceed directly to resection. Thus, our aim was to elucidate the impact of preoperative biliary drainage of obstructive jaundice due to malignant pancreatic head tumors on postoperative morbidity and mortality. ...
There is no clear consensus on whether to treat malignant obstructive jaundice with preoperative biliary drainage prior to ope …
Hepatectomy for Hepatocellular Carcinoma with Bile Duct Tumor Thrombus, Including Cases with Obstructive Jaundice.
Orimo T, et al. Ann Surg Oncol 2016. PMID 27006124 Free article.
The authors analyzed the impact of BDTT on the surgical outcomes and assessed the outcomes of hepatectomy for patients presenting with obstructive jaundice. ...The HCC patients with BDTT who presented with obstructive jaundice demonstrated outcomes similar to those for the HCC patients with BDTT who did not present with obstructive jaundice in terms of the overall survival rate (p = 0.5469). ...
The authors analyzed the impact of BDTT on the surgical outcomes and assessed the outcomes of hepatectomy for patients presenting with ob
Clinical Interpretation of Elevated CA 19-9 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary Disease.
Kim MS, et al. Korean J Gastroenterol 2017. PMID 28830135 Free article.
BACKGROUND/AIMS: Elevated carbohydrate antigen (CA) 19-9 level may be unable to differentiate between benign and malignant pancreatobiliary disease with obstructive jaundice. The study aims to determine the clinical interpretation and the diagnostic value of CA 19-9 level in pancreatobiliary diseases with coexistent obstructive jaundice. ...
BACKGROUND/AIMS: Elevated carbohydrate antigen (CA) 19-9 level may be unable to differentiate between benign and malignant pancreatobiliary …
314 results
Jump to page
Feedback